In short

Two checks do most of the work: confirm the pharmacy holds a current licence with the state board where it operates and where you live, and confirm whether.

By Alsen Walker · Updated September 22, 2026

Two checks do most of the work: confirm the pharmacy holds a current licence with the state board where it operates and where you live, and confirm whether it is a 503A pharmacy or an FDA-registered 503B outsourcing facility. Both are public records. A provider unwilling to name its source has answered a different question.

For the wider picture on compounded products and how to check a supplier, see Compounded GLP-1s: What They Are and How to Check a Supplier.

Check the licence

Every state has a board of pharmacy with a public licence lookup. Search the pharmacy name and confirm the licence is current and in good standing.

Pharmacies shipping into a state generally need to be licensed there as well as where they operate. If a pharmacy is licensed in one state and shipping to yours, check whether it holds a non-resident licence for your state.

Look for disciplinary history while you are there. Boards publish actions taken, and that record is worth two minutes of your time.

Check the facility type

FDA publishes a list of registered outsourcing facilities. If the provider claims 503B status, it should appear there.

If it is a 503A pharmacy, oversight is at state level and manufacturing standards are not the same. That is not disqualifying, and it is information you should have.

Ask these questions directly

Which pharmacy or facility prepares the product, by name.

Which substance it contains, specifically. Semaglutide base is not the same as semaglutide sodium or acetate.

What concentration, in writing, since dosing instructions from elsewhere may not apply.

Whether a certificate of analysis is available for the batch.

Who the prescriber is, whether they are licensed in your state, and how to contact them if something goes wrong.

What happens if the regulatory position changes.

Signs to take seriously

Refusal to name the pharmacy or facility. This alone is sufficient reason to stop.

No named, contactable prescriber, or a consultation that consists of a form with no clinical review.

Claims that a compounded product is FDA-approved. That statement is false and tells you what kind of operation you are dealing with.

Selling without a prescription at all.

Pressure tactics: countdown timers, bulk discounts, subscriptions difficult to cancel.

Concentration or dosing instructions given in insulin units rather than milligrams, without clear conversion.

Verify the prescriber too

State medical boards publish licence lookups. A legitimate telehealth service uses prescribers licensed in your state, and that is checkable.

If you cannot identify who prescribed your medication, you do not have a prescriber. You have a seller.

If something goes wrong

Seek medical care and tell them exactly what you took, including the source.

Report it to FDA MedWatch, and to your state board of pharmacy. Reports are how patterns get identified, and individual complaints are what trigger investigations.

Frequently asked questions

How do I find my state board of pharmacy?
Each state publishes one with an online licence lookup. Search the state name and board of pharmacy.

What if the pharmacy is in another state?
Check both its home state licence and whether it holds a non-resident licence for yours.

Should I ask for a certificate of analysis?
Reasonable to ask. How the provider responds is informative in itself.

Is a nice website evidence of legitimacy?
No. Presentation is the cheapest thing to buy.

What if they will not say which pharmacy?
Stop there. That is not a question a legitimate operation avoids.

Where do I report a problem?
FDA MedWatch and your state board of pharmacy.

Alsen Walker is a health writer and researcher at GLP1Hub with five years of experience researching and writing health and medical content. He works in a medical-field role alongside his undergraduate studies. At GLP1Hub he researches GLP-1 weight loss programs, pricing and insurance rules, and checks claims against FDA prescribing information, published clinical trials and official government sources. Alsen is not a physician, and his articles are general information, not medical advice.